
C-Mune Therapeutics Private Limited
About C-Mune Therapeutics Private Limited
Data last updated:
C-Mune Therapeutics Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the hardware consulting segment of the professional services sector. It was incorporated on 28 March 2024.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U72100TS2024PTC183840.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹10,000. It is led by directors Akhilesh Kumar Srivastava and Vijay Kumar Raina.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at M/S Atal Incubation Centre – Centre For Cellular And Molecular Biology (Aic – Ccmb), Medical Biotechnology Complex Ccmb Annex – 2 Ida Uppal Genpact Road Hyderabad, Telangana, India – 500039.
Company details
Contact details
C-Mune Therapeutics Private Limited's registered office is in Hyderabad, Telangana.
- Registered AddressM/S Atal Incubation Centre – Centre For Cellular And Molecular Biology (Aic – Ccmb), Medical Biotechnology Complex Ccmb Annex – 2 Ida Uppal Genpact Road Hyderabad, Telangana, India – 500039
- IndustryProfessional Services, Hardware Consulting
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of C-Mune Therapeutics Private Limited
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ||
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ||
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | ||
| Net Profit Margin | ||
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of C-Mune Therapeutics Private Limited, buy the company report.
Board of directors of C-Mune Therapeutics Private Limited
C-Mune Therapeutics has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Akhilesh Kumar Srivastava | Director | 28 Mar 2024 | 2 Years 7 Months | Current |
| Vijay Kumar Raina | Director | 28 Mar 2024 | 2 Years 7 Months | Current |
Legal cases
No court or tribunal cases involving C-Mune Therapeutics Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for C-Mune Therapeutics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for C-Mune Therapeutics Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
C-Mune Therapeutics Private Limited has 2 board changes on record since 2024: 2 appointments. The latest: Akhilesh Kumar Srivastava was appointed as Director on 28 Mar 2024.
Frequently asked questions
C-Mune Therapeutics is an active private limited company based in Hyderabad, Telangana, India. The company works in hardware consulting, within the professional services industry. It was incorporated on 28 March 2024 (2+ years old) and is registered under CIN U72100TS2024PTC183840.
C-Mune Therapeutics has 2 current directors:
- Akhilesh Kumar Srivastava - Director
- Vijay Kumar Raina - Director
The latest financial statements of C-Mune Therapeutics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2024 are in the company report.
The CIN (Corporate Identification Number) of C-Mune Therapeutics is U72100TS2024PTC183840. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
C-Mune Therapeutics was incorporated on 28 March 2024, making it 2+ years old. It is registered with the Registrar of Companies, Hyderabad.
Akhilesh Kumar Srivastava was appointed as Director on 28 Mar 2024. Vijay Kumar Raina was appointed as Director on 28 Mar 2024.
The registered office of C-Mune Therapeutics is at MS Atal Incubation Centre – Centre For Cellular And Molecular Biology Aic – Ccmb, Medical Biotechnology Complex Ccmb Annex – 2 Ida Uppal Genpact Road Hyderabad, Telangana, India – 500039.
C-Mune Therapeutics operates in the professional services industry, in the hardware consulting segment.
C-Mune Therapeutics can be reached at its registered office: MS Atal Incubation Centre – Centre For Cellular And Molecular Biology Aic – Ccmb, Medical Biotechnology Complex Ccmb Annex – 2 Ida Uppal Genpact Road Hyderabad, Telangana, India – 500039.
C-Mune Therapeutics is registered under the jurisdiction of the Registrar of Companies (ROC), Hyderabad.

